"At Baylor Scott & White Research Institute, you are at the heart of everything we do. This philosophy extends to our research, where we focus on breakthroughs that mean something to you—a more accurate diagnosis, a faster recovery or a more effective treatment. Our research brings innovation from our laboratory to your bedside."

During the past decade, Research Baylor Institute of Metabolic Disease conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Baylor Institute of Metabolic Disease" #1 collaborator was "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Rare Diseases Clinical Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Research Baylor Institute of Metabolic Disease" are "Fabry Disease" (6 trials) and "Mucolipidosis Type IV" (1 trials). Many other conditions were trialed in "Research Baylor Institute of Metabolic Disease" in a lesser frequency.

Most popular intervention types in "Research Baylor Institute of Metabolic Disease" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lucerastat" (2 trials), "PRX-102" (1 trials), "PRX-102 (pegunigalsidase alfa)" (1 trials), "Pegunigalsidase alfa" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Research Baylor Institute of Metabolic Disease" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Research Baylor Institute of Metabolic Disease". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Research Baylor Institute of Metabolic Disease, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Research Baylor Institute of Metabolic Disease, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".